Californians will be able to buy five packs of insulin pens for a maximum of $55 per pack, or $11 per pen, starting Jan. 1, ...
A PwC analysis shows that GLP-1 medications like Ozempic and Zepbound may be catalyzing a behavioral and economic shift that’s on par with major technological breakthroughs. A transformation that ...
The state-branded, life-saving drugs for some 3.5 million Californians with diabetes will be much cheaper, the governor ...
The first CalRx product will be long-acting glargine insulin pens, the generic version of Lantus, used to regulate blood ...
California will start selling state-branded insulin pens in January, cementing a 2023 promise Gov. Gavin Newsom made to tap ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback